Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Nov;52(11):780–784. doi: 10.1136/ard.52.11.780

Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone.

L Martin 1, J D Pauls 1, J P Ryan 1, M J Fritzler 1
PMCID: PMC1005188  PMID: 8250609

Abstract

OBJECTIVES--The role of autoantibodies in the investigation and management of rheumatic diseases is well recognised. The objective of this study was to determine the clinical significance of the co-occurrence of antibodies to centromere and histone in serum samples from patients investigated for systemic rheumatic diseases. METHODS--Serum samples from 1316 consecutive patients were screened for antinuclear antibodies and the clinical findings in patients with antibodies to centromere alone were compared with those with antibodies to both centromere and histone. RESULTS--Twenty six patients had antibodies to centromere. Fourteen patients had antibodies to centromere alone and 12 patients had antibodies to centromere and histone. Four of the 12 patients with antibodies to centromere and histone had diffuse scleroderma with severe pulmonary or vascular disease. CONCLUSIONS--A subset of patients with scleroderma with antibodies to centromere and histone has been identified retrospectively, who have severe pulmonary or vascular disease. It will be of interest to follow up the clinical course of other patients with scleroderma who have both antibodies for the development of pulmonary or vascular disease.

Full text

PDF
780

Images in this article

781Image
on p.781
782Image
on p.782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein R. M., Morgan S. H., Chapman J., Bunn C. C., Mathews M. B., Turner-Warwick M., Hughes G. R. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984 Jul 21;289(6438):151–152. doi: 10.1136/bmj.289.6438.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Douvas A. S., Achten M., Tan E. M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979 Oct 25;254(20):10514–10522. [PubMed] [Google Scholar]
  3. Flores R. H., Stevens M. B., Arnett F. C. Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus. J Rheumatol. 1984 Jun;11(3):321–323. [PubMed] [Google Scholar]
  4. Franco H. L., Weston W. L., Peebles C., Forstot S. L., Phanuphak P. Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J Am Acad Dermatol. 1981 Jan;4(1):67–72. doi: 10.1016/s0190-9622(81)70011-2. [DOI] [PubMed] [Google Scholar]
  5. Fritzler M. J. Autoantibody testing: procedures and significance in systemic rheumatic diseases. Methods Achiev Exp Pathol. 1986;12:224–260. [PubMed] [Google Scholar]
  6. Fritzler M. J., Hart D. A. Prolonged improvement of Raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapy. Arthritis Rheum. 1990 Feb;33(2):274–276. doi: 10.1002/art.1780330218. [DOI] [PubMed] [Google Scholar]
  7. Fritzler M. J., Kinsella T. D. The CREST syndrome: a distinct serologic entity with anticentromere antibodies. Am J Med. 1980 Oct;69(4):520–526. doi: 10.1016/0002-9343(80)90462-3. [DOI] [PubMed] [Google Scholar]
  8. Fritzler M. J., Tan E. M. Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J Clin Invest. 1978 Sep;62(3):560–567. doi: 10.1172/JCI109161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gohill J., Fritzler M. J. Antibodies in procainamide-induced and systemic lupus erythematosus bind the C-terminus of histone 1 (H1). Mol Immunol. 1987 Mar;24(3):275–285. doi: 10.1016/0161-5890(87)90146-5. [DOI] [PubMed] [Google Scholar]
  10. Moroi Y., Peebles C., Fritzler M. J., Steigerwald J., Tan E. M. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1627–1631. doi: 10.1073/pnas.77.3.1627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Moteki S., Yoshida H., Nishimaki T., Morito T. [The significance of autoantibodies coexisting with anti-centromere antibodies in sera of patients with primary biliary cirrhosis]. Rinsho Byori. 1990 Aug;38(8):888–894. [PubMed] [Google Scholar]
  12. Palmer D. K., Margolis R. L. Kinetochore components recognized by human autoantibodies are present on mononucleosomes. Mol Cell Biol. 1985 Jan;5(1):173–186. doi: 10.1128/mcb.5.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Palmer D. K., O'Day K., Trong H. L., Charbonneau H., Margolis R. L. Purification of the centromere-specific protein CENP-A and demonstration that it is a distinctive histone. Proc Natl Acad Sci U S A. 1991 May 1;88(9):3734–3738. doi: 10.1073/pnas.88.9.3734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Palmer D. K., O'Day K., Wener M. H., Andrews B. S., Margolis R. L. A 17-kD centromere protein (CENP-A) copurifies with nucleosome core particles and with histones. J Cell Biol. 1987 Apr;104(4):805–815. doi: 10.1083/jcb.104.4.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pauls J. D., Silverman E., Laxer R. M., Fritzler M. J. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1989 Jul;32(7):877–883. [PubMed] [Google Scholar]
  16. Provost T. T. Commentary: neonatal lupus erythematosus. Arch Dermatol. 1983 Jul;119(7):619–622. [PubMed] [Google Scholar]
  17. Steen V. D., Powell D. L., Medsger T. A., Jr Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988 Feb;31(2):196–203. doi: 10.1002/art.1780310207. [DOI] [PubMed] [Google Scholar]
  18. Tan E. M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989;44:93–151. doi: 10.1016/s0065-2776(08)60641-0. [DOI] [PubMed] [Google Scholar]
  19. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  20. Valdivia M. M., Brinkley B. R. Fractionation and initial characterization of the kinetochore from mammalian metaphase chromosomes. J Cell Biol. 1985 Sep;101(3):1124–1134. doi: 10.1083/jcb.101.3.1124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wasicek C. A., Reichlin M. Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest. 1982 Apr;69(4):835–843. doi: 10.1172/JCI110523. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES